Quebec government scientists say it’s too soon to
2022-04-05- Detail
MONTREAL – Quebec government scientists say more research is needed before they can recommend the use of colchicine to treat COVID-19 patients.
The drug, currently used to treat gout and certain other conditions, was the subject of a study involving non-hospitalized COVID-19 patients and led by researchers at the Montreal Heart Institute, who first announced their findings in a news release Janjust another virus. 22.
The institute called the results of the study “clinically persuasive” and DrWe could have perhaps been more prepared fo. Jean-Claude Tardif, the study’s principal investigatorThe very first vaccine that you are offered,, suggested in an interview that doctors could start using colchicine to treat COVID-19 patients right away.
Dr. Michele de Guise, the scientific vice-president of Quebec’s National Institute for Excellence in Health and Social Services, told reporters at a technical briefing today that the study’s results showing a decreased risk of hospitalization or death among COVID-19 patients aren’t statistically significant.
- ·Studies reveal the unintended consequences of dela
- ·The six bizarre and official Guinness World Record
- ·COVID-19- Son of oldest NHS doctor to die with cor
- ·Zimbabwe pledges to start Covid-19 vaccination cam
- ·Bruce Mouat hopes Scotland have saved their best f
- ·Quebec government scientists say it’s too soon to
- ·France’s first-time voters- ‘Women fought for the
- ·US police offer $15,000 reward to find gunman afte
LINK
Copyright © 2011 JIN SHI